– Two poster presentations highlighting new preclinical data with BlueRock Therapeutics – – Two poster presentations showcasing Senti Bio’s proprietary Gene Circuit platform – SOUTH SAN.
– Two poster presentations highlighting new preclinical data with BlueRock Therapeutics – – Two poster presentations showcasing Senti Bio’s proprietary.
Looking for the latest GovCon News? Check out our story: NGA Taps 5 Small Businesses for $947M Acquisition, Financial Management Support. Click to read more!
20.05.2023 - Five presentations showcase the modularity and applicability of Senti’s Gene Circuit technology in NK cells, T cells, AAVs, iPSCs, and macrophagesSOUTH SAN FRANCISCO, Calif., May 20, 2023 (GLOBE NEWSWIRE) - Senti Biosciences, Inc. (Nasdaq: SNTI) . Seite 1